All resources
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Blog
How a Multi-Platform Randomized Clinical Trial Impacted the COVID-19 Pandemic
REMAP-CAP, ATTACC, and ACTIV-4a unified under a multi-platform randomized clinical trial with a joint Bayesian adaptive design, rapidly determining that therapeutic anticoagulation benefits moderate, but not severe, COVID-19 patients.
Podcast Episode
62: Multi-Platform RCT
In this episode of "In the Interim…", Dr. Scott Berry details the design, execution, and results of the multi-platform Randomized Clinical Trial (mpRCT) pioneered during the COVID-19 pandemic.
News and Events
Episode 62, “Multi-Platform RCT”
In this episode of "In the Interim…", Dr. Scott Berry details the design, execution, and results of the multi-platform randomized clinical trial (mpRCT) pioneered during the COVID-19 pandemic.
Podcast Episode
61: Sports and Clinical Trials: The 1927 Yankees, 15 Tarzans, and Modern Athletes
In this episode of "In the Interim…", Dr. Scott Berry examines the analytical challenges of comparing performance across eras in both sports and clinical research.
News and Events
Episode 61, “Sports and Clinical Trials: The 1927 Yankees, 15 Tarzans, and Modern Athletes”
In this episode of "In the Interim…", Dr. Scott Berry examines the analytical challenges of comparing performance across eras in both sports and clinical research.
Podcast Episode
60: AI @ Berry
In the 60th episode of "In the Interim…", Dr. Scott Berry, Dr. Nick Berry, and Dr. Joe Marion discuss how Berry Consultants uses AI in clinical trial design and software development.
No results found.
There are no results with this criteria. Try changing your search.
